Para-Buster

Friday, December 23, 2011

New Tests Might Better Predict Breast Cancer's Return

(HealthDay News) -- New research points to two gene-based methods of predicting if and when women with certain breast cancers will experience a tumor recurrence.

The studies, involving two common forms of breast cancer, are slated to be presented Wednesday at the 2011 San Antonio Breast Cancer Symposium.

The research also revealed that genetic data gleaned from tumors might help doctors tailor treatments to individual patients, sparing low-risk women from exposure to unnecessary radiation, for example.

In one study, researchers from the Eastern Cooperative Oncology Group, North Central Cancer Treatment Group and Genomic Health found that a multi-gene test can predict the risk for recurrence among women who have been diagnosed with ductal carcinoma in situ, or DCIS (a type of early cancerous growth limited to the breast duct).

In conducting the study, researchers analyzed genetic information from the tumors of 327 women diagnosed with DCIS, to calculate their risk for recurrence. By differentiating between low-risk and more aggressive forms of the disease, the "DCIS Score" predicts the likelihood of local recurrence and might help doctors determine if patients should be treated with surgery or a combination of surgery and radiation. Read more...

Immunice for Immune Support

No comments:

Dr. Group's Secret to Health Kit

Dr. Group's Secret to Health Kit

$39.94
[ learn more ]

Add to Cart

Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness.

Advanced Body Cleansing Kit

Advanced Body Cleansing Kit

$147.75
[ learn more ]

Add to Cart

Advanced Body Cleansing Kit with Livatrex™, Oxy-Powder®, Latero-Flora™ and two bottles of ParaTrex®.